541 related articles for article (PubMed ID: 27517491)
1. Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment.
Selleri C; Montuori N; Salvati A; Serio B; Pesapane A; Ricci P; Gorrasi A; Li Santi A; Hoyer-Hansen G; Ragno P
Oncotarget; 2016 Sep; 7(37):60206-60217. PubMed ID: 27517491
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization.
Selleri C; Montuori N; Ricci P; Visconte V; Carriero MV; Sidenius N; Serio B; Blasi F; Rotoli B; Rossi G; Ragno P
Blood; 2005 Mar; 105(5):2198-205. PubMed ID: 15494432
[TBL] [Abstract][Full Text] [Related]
3. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.
Selleri C; Montuori N; Ricci P; Visconte V; Baiano A; Carriero MV; Rotoli B; Rossi G; Ragno P
Cancer Res; 2006 Nov; 66(22):10885-90. PubMed ID: 17108125
[TBL] [Abstract][Full Text] [Related]
4. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.
Mustjoki S; Sidenius N; Sier CF; Blasi F; Elonen E; Alitalo R; Vaheri A
Cancer Res; 2000 Dec; 60(24):7126-32. PubMed ID: 11156421
[TBL] [Abstract][Full Text] [Related]
5. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion.
Aref S; El-Sherbiny M; Mabed M; Menessy A; El-Refaei M
Hematology; 2003 Dec; 8(6):385-91. PubMed ID: 14668033
[TBL] [Abstract][Full Text] [Related]
6. Analyzing hematopoietic stem cell homing, lodgment, and engraftment to better understand the bone marrow niche.
Heazlewood SY; Oteiza A; Cao H; Nilsson SK
Ann N Y Acad Sci; 2014 Mar; 1310():119-28. PubMed ID: 24428368
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.
Adamiak M; Borkowska S; Wysoczynski M; Suszynska M; Kucia M; Rokosh G; Abdel-Latif A; Ratajczak J; Ratajczak MZ
Oncotarget; 2015 Aug; 6(22):18819-28. PubMed ID: 26299919
[TBL] [Abstract][Full Text] [Related]
8. Soluble urokinase plasminogen activator receptor during allogeneic stem cell transplantation.
Haastrup E; Andersen J; Ostrowski SR; Høyer-Hansen G; Jacobsen N; Heilmann C; Ullum H; Müller K
Scand J Immunol; 2011 Apr; 73(4):325-9. PubMed ID: 21223347
[TBL] [Abstract][Full Text] [Related]
9. Blockade of plasminogen activator inhibitor-1 empties bone marrow niche sufficient for donor hematopoietic stem cell engraftment without myeloablative conditioning.
Ibrahim AA; Yahata T; Muguruma Y; Miyata T; Ando K
Biochem Biophys Res Commun; 2019 Aug; 516(2):500-505. PubMed ID: 31230745
[TBL] [Abstract][Full Text] [Related]
10. Mobilization and homing of hematopoietic stem cells.
Suárez-Álvarez B; López-Vázquez A; López-Larrea C
Adv Exp Med Biol; 2012; 741():152-70. PubMed ID: 22457109
[TBL] [Abstract][Full Text] [Related]
11. Age-related differences in the bone marrow stem cell niche generate specialized microenvironments for the distinct regulation of normal hematopoietic and leukemia stem cells.
Lee GY; Jeong SY; Lee HR; Oh IH
Sci Rep; 2019 Jan; 9(1):1007. PubMed ID: 30700727
[TBL] [Abstract][Full Text] [Related]
12. SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors.
Khurana S; Melacarne A; Yadak R; Schouteden S; Notelaers T; Pistoni M; Maes C; Verfaillie CM
Stem Cells; 2014 Nov; 32(11):3012-22. PubMed ID: 25069965
[TBL] [Abstract][Full Text] [Related]
13. Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients.
Sloand EM; Pfannes L; Scheinberg P; More K; Wu CO; Horne M; Young NS
Exp Hematol; 2008 Dec; 36(12):1616-24. PubMed ID: 18954937
[TBL] [Abstract][Full Text] [Related]
14. Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells.
Alfano D; Gorrasi A; Li Santi A; Ricci P; Montuori N; Selleri C; Ragno P
J Cell Mol Med; 2015 Sep; 19(9):2262-72. PubMed ID: 26082201
[TBL] [Abstract][Full Text] [Related]
15. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
Isaikina Y; Shman T
Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
[TBL] [Abstract][Full Text] [Related]
16. Pre-Transplantation Blockade of TNF-α-Mediated Oxygen Species Accumulation Protects Hematopoietic Stem Cells.
Ishida T; Suzuki S; Lai CY; Yamazaki S; Kakuta S; Iwakura Y; Nojima M; Takeuchi Y; Higashihara M; Nakauchi H; Otsu M
Stem Cells; 2017 Apr; 35(4):989-1002. PubMed ID: 27753160
[TBL] [Abstract][Full Text] [Related]
17. The urokinase receptor in hematopoietic stem cells mobilization.
Blasi F
Curr Pharm Des; 2011; 17(19):1911-3. PubMed ID: 21711240
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia.
Erkut N; Menteşe A; Özbaş HM; Ermantaş N; Sümer A; Örem A; Sönmez M
Turk J Haematol; 2016 Jun; 33(2):135-40. PubMed ID: 26376588
[TBL] [Abstract][Full Text] [Related]
19. IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation.
Caselli A; Olson TS; Otsuru S; Chen X; Hofmann TJ; Nah HD; Grisendi G; Paolucci P; Dominici M; Horwitz EM
Stem Cells; 2013 Oct; 31(10):2193-204. PubMed ID: 23818291
[TBL] [Abstract][Full Text] [Related]
20. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells.
Aerts-Kaya F; Kilic E; Köse S; Aydin G; Cagnan I; Kuskonmaz B; Uckan-Cetinkaya D
Cytokine; 2021 Mar; 139():155407. PubMed ID: 33383380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
